scholarly article | Q13442814 |
P356 | DOI | 10.1038/SJ/EYE/6700095 |
P698 | PubMed publication ID | 11988817 |
P2093 | author name string | C Evereklioglu | |
H Er | |||
S Doganay | |||
Y Türköz | |||
A Sevinç | |||
H Savli | |||
N Mehmet | |||
P433 | issue | 2 | |
P304 | page(s) | 163-170 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Eye | Q10278937 |
P1476 | title | Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus | |
P478 | volume | 16 |
Q52633243 | (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy. |
Q92670822 | A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy |
Q41883466 | Angiogenic Factors and Cytokines in Diabetic Retinopathy |
Q37304677 | Animal models of diabetic retinopathy: summary and comparison |
Q35133785 | Antihypertensive effect of radix paeoniae alba in spontaneously hypertensive rats and excessive alcohol intake and high fat diet induced hypertensive rats |
Q50962850 | Aqueous humor pentraxin-3 levels in patients with diabetes mellitus. |
Q46443789 | Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy |
Q24644700 | BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells |
Q64093346 | Biological Characteristics of Subsilicone Oil Fluid and Differences With Other Ocular Humors |
Q38143091 | Candidate genes for proliferative diabetic retinopathy |
Q26744760 | Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology |
Q36379507 | Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects |
Q53612326 | Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy. |
Q35068037 | Complement gene expression and regulation in mouse retina and retinal pigment epithelium/choroid |
Q37084522 | Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy |
Q33738829 | Current and future management of diabetic retinopathy: a personalized evidence-based approach |
Q33791268 | Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation. |
Q81473347 | Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy |
Q92130384 | Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network |
Q58579972 | Diabetic Retinopathy: A complex pathophysiology requiring novel therapeutic strategies |
Q38542115 | Diabetic Retinopathy: Vascular and Inflammatory Disease. |
Q35087841 | Diabetic complications and dysregulated innate immunity |
Q41012046 | Diabetic retinopathy and inflammation: novel therapeutic targets. |
Q35762905 | Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy |
Q37362491 | Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. |
Q34710173 | Effects of fenofibrate on adiponectin expression in retinas of streptozotocin-induced diabetic rats |
Q37501293 | Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation. |
Q28199738 | Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus |
Q92773331 | Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients |
Q35736321 | Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. |
Q39291225 | Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells. |
Q33979446 | High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy |
Q43143286 | High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome. |
Q36756478 | Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators |
Q43137697 | IL-2 and IFN-gamma in the retina of diabetic rats. |
Q36180464 | Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators |
Q38167309 | Inflammation and pharmacological treatment in diabetic retinopathy |
Q98288337 | Inflammatory and angiogenic biomarkers in diabetic retinopathy |
Q37095335 | Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes |
Q45001821 | Inflammatory markers and retinopathy in pregnancies complicated with type I diabetes |
Q33607728 | Interleukin-13 and age-related macular degeneration |
Q51811242 | Intraocular Inflammation in Diabetic Populations. |
Q94600699 | Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol |
Q36082148 | Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications |
Q37165322 | Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to Glucose |
Q34273776 | Maternal immune system adaptation to pregnancy - a potential influence on the course of diabetic retinopathy |
Q37734972 | Mesenchymal stem cells: new players in retinopathy therapy |
Q54122676 | Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo. |
Q26745555 | Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future? |
Q28078199 | Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy |
Q34011852 | Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy |
Q91643048 | Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy |
Q92086083 | OMICs approaches-assisted identification of macrophages-derived MIP-1γ as the therapeutic target of botanical products TNTL in diabetic retinopathy |
Q97550134 | Obesity-associated T-cell and macrophage activation improve partly after a lifestyle intervention |
Q89659788 | Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile |
Q26865897 | Pathophysiology of diabetic retinopathy |
Q40072270 | Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in adult-onset familial Mediterranean fever. |
Q36318318 | Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema |
Q36294444 | Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus |
Q37697860 | Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy |
Q47361893 | Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration. |
Q38237215 | Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain |
Q35220258 | Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease |
Q42756101 | Proliferation and Migration of Peripheral Retinal Pigment Epithelial Cells Are Associated with the Upregulation of Wingless-Related Integration and Bone Morphogenetic Protein Signaling in Dark Agouti Rats |
Q90311340 | Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy |
Q79169175 | Relation between plasma nitric oxide levels and diabetic retinopathy |
Q92594491 | Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography |
Q52642996 | Role of Inflammation in Diabetic Retinopathy. |
Q41012127 | Role of inflammation in the pathogenesis of diabetic retinopathy |
Q94483947 | SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease |
Q42722361 | Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children |
Q60947291 | Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications |
Q48277485 | Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography |
Q47123777 | Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy |
Q49551434 | TLR-induced secretion of novel cytokine IL-27 is defective in newly diagnosed type-2 diabetic subjects. |
Q83396664 | The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus |
Q50568033 | The Antioxidant and Antigenotoxic Effects of Pycnogenol® on Rats Treated With Cisplatin |
Q48308877 | The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration. |
Q37647798 | The effects of anti-vascular endothelial growth factor agents on human retinal pigment epithelial cells under high glucose conditions |
Q42115589 | Thrombin-induced VEGF expression in human retinal pigment epithelial cells |
Q35088004 | Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing |
Q35609148 | Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome. |
Q34426246 | Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy |
Search more.